Science Market Update

Harvard and Merck Partner for $20M Cancer Therapeutics Research

Posted by Laura Braden on Mon, Apr 18, 2016

Acute myeloid leukemia (AML) is the most common form of leukemia affecting the blood and bone marrow, and has been responsible for 1.8% of cancer deaths in 2016. Because it is so prevalent, many research teams around the world study this disease in search of new treatment methods. One of these research teams, from Harvard University, has joined up with the pharmaceutical company Merck in a $20 million collaboration to develop new therapeutics for leukemia.

Read More

Tags: Harvard University, Northeast, Leukemia, cancer research, Massachusetts, Boston, BioResearch Product Faire Event, MA, Harvard, longwood, 2016, cancer therapy, Merck

UMinn Science Researchers Find Possible Link: C-Sections & Leukemia

Posted by Katheryn Rein on Thu, Mar 31, 2016

Acute lymphoblastic leukemia (ALL) is the most common type of childhood cancer, affecting nearly 6 thousand children in the US annually. Recently, a possible relationship has been identified, which may provide valuable insight into why this cancer develops and how to prevent it.

Read More

Tags: Lab Product show, University of Minnesota, UMN, Leukemia, cancer research, Minnesota, University of Minnesota Twin Cities, Minneapolis, MN, UMinn, Minn, Twin Cities, uminn research

Emory Researchers Find Anti-Cancer Potential in Lichens and Rhubarb

Posted by Laura Braden on Mon, Nov 30, 2015

Cancer affects the majority of the population in one way or another, through knowing someone with cancer, being exposed to it in the media, or having it oneself. Cancer treatments and cures are some of the most well funded and highly researched areas in the life sciences. Researchers at the Winshop Cancer Institute at Emory University in Atlanta, GA recently discovered that an orange pigment, called parietin or physcion, that is found in lichens and rhubarb has potential to be used as an anti-cancer drug.

Read More

Tags: Emory University, Leukemia, cancer research, Southern, Cancer Treatment, Emory, BioResearch Product Faire Event, Atlanta, GA, Southern Region, 2016, Parietin, physcion

UCSF and OHSU Team Up to Tackle Childhood Leukemia

Posted by Robert Larkin on Mon, Apr 27, 2015

Scientists from UC San Francisco and Oregon Health & Science University (OHSU) have teamed up to tackle acute lymphoblastic leukemia (ALL), a blood cancer that typically affects children from two to five years old.

Read More

Tags: CA, Leukemia, Oregon Health and Science University, cancer research, Oregon, California, Pediatric Cancer Research, 2015, San Francisco, SFVS, BioResearch Product Faire Event, OR, UCSF, OHSU, Portland, UC San Francisco, Biotechnology Vendor Showcase Event

UCSF Makes Lemonade, Receives $1.35M for Pediatric Bioresearch

Posted by Robert Larkin on Tue, Jan 20, 2015

When life gives you lemons, make lemonade… and if you’ve got lemonade, make a lemonade stand. However, when Alex’s Lemonade Stand Foundation gives you millions in research funding, now you can help cure childhood cancer. Thanks to a little girl who once made lemonade to raise money for childhood cancer research, two UC San Francisco faculty members are among researchers being nationally acknowledged for their work in pediatric oncology.

Read More

Tags: CA, Bioresearch funding, Leukemia, California, Pediatric Cancer Research, grants, 2015, Biotechnology, Life Science, UCSF, San Francisco at Mission Bay, cancer research funding, Biotechnology Vendor Showcase Event

Cell Engineering Wipes Out Leukemia in Translational Research Triumph

Posted by Jaimee Saliba on Fri, Mar 22, 2013

Memorial Sloan-Kettering Cancer Center cell engineering researchers and their clinician colleagues have been in the news recently for a successful experimental cell therapy. Called targeted immunotherapy, a patient's T cells are genetically altered in the lab, then reintroduced with the directive to target and kill cancer cells. The treatment was carried out on a group of adults who all suffered from a rapidly progressing form of leukemia that had not responded to chemotherapy. All five went into remission after the novel cell treatment, and three have stayed that way for a number of months. Results of the ongoing clinical trial appeared in the March 20 online edition of the journal Science Translational Medicine, along with an article in the New York Times.

Read More

Tags: 2014, Rockefeller University, 2013, Northeast, Leukemia, immunotherapy, cancer research, New York, Memorial Sloan-Kettering Cancer Center, Cancer Treatment, Immune System, Cell Research, RockU, BioResearch Product Faire Event, NY, New York City, MSKCC

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News